Healthcare Resource Utilization and Costs Associated with Autosomal Dominant Polycystic Kidney Disease
**Background:** Autosomal dominant polycystic kidney disease (ADPKD), a hereditary nephropathy, eventually leads to end-stage renal disease (ESRD), typically by mid-life. **Objectives:** The objective of this study was to assess real-world healthcare resource utilization and cost among commercially...
Saved in:
Main Authors: | Christopher M. Blanchette, Şerban R. Iorga, Aylin Altan, Jerry G. Seare, Ying Fan, Sandro Rossetti, Benjamin Gutierrez |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2014-07-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/9889 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting TRPM3 as a potential therapeutic approach for autosomal dominant polycystic kidney disease
by: Hüseyin Gül, et al.
Published: (2025-02-01) -
A new atypical splice mutation in PKD2 leading to autosomal dominant polycystic kidney disease in a Chinese family
by: Junlin Zhang, et al.
Published: (2024-04-01) -
The Dominance of Homeopathic Medicine in Yoruba Healthcare Delivery
by: Richard Taye Oyelakin
Published: (2023-05-01) -
Healthcare Resource Utilization Associated with Leukopenia and Neutropenia in Kidney Transplant Recipients Receiving Valganciclovir in the United States
by: Qinghua Li, et al.
Published: (2025-01-01) -
Mastalgia Assesment and Hormonal Correlations in Patients with Polycystic Ovary Syndrome
by: Emel Kıyak Çağlayan, et al.
Published: (2015-04-01)